Search Results - "Altomare, G"

Refine Results
  1. 1
  2. 2

    Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal Domain by Altomare, Clara G, Adelsberg, Daniel C, Carreno, Juan Manuel, Sapse, Iden A, Amanat, Fatima, Ellebedy, Ali H, Simon, Viviana, Krammer, Florian, Bajic, Goran

    Published in mBio (25-04-2022)
    “…Structural characterization of infection- and vaccination-elicited antibodies in complex with antigen provides insight into the evolutionary arms race between…”
    Get full text
    Journal Article
  3. 3

    Nonsensory target-dependent organization of piriform cortex by Chen, Chien-Fu F., Zou, Dong-Jing, Altomare, Clara G., Xu, Lu, Greer, Charles A., Firestein, Stuart J.

    “…The piriform cortex (PCX) is the largest component of the olfactory cortex and is hypothesized to be the locus of odor object formation. The distributed…”
    Get full text
    Journal Article
  4. 4

    Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence by Lombardi, G, Perego, S, Sansoni, V, Diani, M, Banfi, G, Altomare, G

    Published in BMJ open (01-12-2016)
    “…ObjectiveAdalimumab has proven effective in psoriasis; however, secondary failure may result from the drug's immunogenicity. Prevalence data on the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Consensus on the management of patients with psoriatic arthritis in a dermatology setting by Gisondi, P., Altomare, G., Ayala, F., Conti, A., Dapavo, P., De Simone, C., Foti, C., Idolazzi, L., Lubrano, E., Malara, G., Marchesoni, A., Olivieri, I., Parodi, A., Peris, K., Piaserico, S., Salvarani, C., Scarpa, R., Girolomoni, G.

    “…Background Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with psoriasis (PsO). Early diagnosis and prompt therapeutic intervention are…”
    Get full text
    Journal Article Conference Proceeding
  7. 7
  8. 8

    PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/practically sustainable and evidence-based algorithm by Linder, D., Altomare, G., Amato, S., Amerio, P., Balato, N., Campanati, A., Conti, A., Gisondi, P., Prignano, F., Saraceno, R., Piaserico, S.

    “…Background There is increasing awareness of the clinical relevance of psoriasis comorbidities and of the importance of timely and effective screening for such…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Moderate and severe plaque psoriasis: cost-of-illness study in Italy by Colombo, Gl, Altomare, Gf, Peris, K, Martini, P, Quarta, G, Congedo, M, Costanzo, A, Di Cesare, A, Lapucci, E, Chimenti, S

    Published in Therapeutics and clinical risk management (01-04-2008)
    “…Psoriasis is a chronic inflammatory, immune-mediated skin disorder that affects 1.5-1.8 million people in Italy. The most common form of the disease is chronic…”
    Get full text
    Journal Article
  11. 11

    Severe psoriasis treated with a new macrolide: everolimus by Frigerio, E., Colombo, M.D., Franchi, C., Altomare, A., Garutti, C., Altomare, G.F.

    Published in British journal of dermatology (1951) (01-02-2007)
    “…Summary Psoriasis is an immune‐mediated disease with a chronic relapsing course, and the particularly severe forms that are refractory to traditional therapies…”
    Get full text
    Journal Article
  12. 12

    Etanercept therapy in patients with psoriasis and concomitant HCV infection by Garavaglia, M C, Altomare, G

    “…Treatment of patients with psoriasis and/or psoriatic arthritis and concomitant hepatitis C infection remains difficult. Except for cyclosporine, other drugs…”
    Get more information
    Journal Article
  13. 13

    Psoriasis relapse evaluation with week-end cyclosporine A treatment: results of a randomized, double-blind, multicenter study by Colombo, D, Cassano, N, Altomare, G, Giannetti, A, Vena, G A

    “…Cyclosporine A (CsA) effectively controls psoriasis, however, its long-term continuous use is not recommended. This study aims to evaluate the efficacy and…”
    Get more information
    Journal Article
  14. 14
  15. 15

    P157 Inhibition of CCR7/CCL19 axis in psoriatic plaques is an early critical event for the clinical response to anti-TNF Therapy in psoriasis patients by Bose’, F., Petti, L., Molteni, S., Diani, M., Moscheni, C., Altomare, A., Rossi, R., Altomare, G., Reali, E.

    Published in Cytokine (Philadelphia, Pa.) (01-09-2012)
    “…Psoriasis is a chronic inflammatory skin disease affecting approximately 2% of the population. Important clinical benefits in the treatment of psoriasis have…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The protein kinase C inhibitor AEB071 (sotrastaurin) modulates migration and superoxide anion production by human neutrophils in vitro by Capsoni, F, Ongari, A M, Reali, E, Bosè, F, Altomare, G F

    “…We examined the effect of the protein kinase C-selective inhibitor AEB071 (sotrastaurin) on neutrophil functions in vitro. Pre-incubation with AEB071 at…”
    Get more information
    Journal Article
  18. 18

    An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease by Marchesoni, A, Altomare, G, Matucci-Cerinic, M, Balato, N, Olivieri, I, Salvarani, C, Lotti, T, Scarpa, R, Vena, GA, Valesini, G, Giannetti, A

    “…Background  As psoriatic disease (PD) is a condition characterized by the combination of inflammatory skin (psoriasis) and osteo‐articular manifestations…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Clinical outcome evaluation following cyclosporine a treatment in moderate to severe psoriasis: a retrospective study by Colombo, D, Flori, L, Altomare, G, Aste, N, Sgarbi, S

    “…This retrospective study was conducted on 193 patients treated in three Italian Psoriasis Units with the aim of evaluating the evolution of psoriasis severity…”
    Get more information
    Journal Article